These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 31099946)

  • 1. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system.
    Ekhlaspour L; Forlenza GP; Chernavvsky D; Maahs DM; Wadwa RP; Deboer MD; Messer LH; Town M; Pinnata J; Kruse G; Kovatchev BP; Buckingham BA; Breton MD
    Pediatr Diabetes; 2019 Sep; 20(6):759-768. PubMed ID: 31099946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study.
    Breton MD; Cherñavvsky DR; Forlenza GP; DeBoer MD; Robic J; Wadwa RP; Messer LH; Kovatchev BP; Maahs DM
    Diabetes Care; 2017 Dec; 40(12):1644-1650. PubMed ID: 28855239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial.
    Forlenza GP; Ekhlaspour L; Breton M; Maahs DM; Wadwa RP; DeBoer M; Messer LH; Town M; Pinnata J; Kruse G; Buckingham BA; Cherñavvsky D
    Diabetes Technol Ther; 2019 Apr; 21(4):159-169. PubMed ID: 30888835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
    Nimri R; Muller I; Atlas E; Miller S; Kordonouri O; Bratina N; Tsioli C; Stefanija MA; Danne T; Battelino T; Phillip M
    Pediatr Diabetes; 2014 Mar; 15(2):91-9. PubMed ID: 23944875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.
    Renard E; Farret A; Kropff J; Bruttomesso D; Messori M; Place J; Visentin R; Calore R; Toffanin C; Di Palma F; Lanzola G; Magni P; Boscari F; Galasso S; Avogaro A; Keith-Hynes P; Kovatchev B; Del Favero S; Cobelli C; Magni L; DeVries JH;
    Diabetes Care; 2016 Jul; 39(7):1151-60. PubMed ID: 27208331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
    Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
    Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Based on Total Daily Insulin in Adolescents with Type 1 Diabetes.
    Schoelwer MJ; Robic JL; Gautier T; Fabris C; Carr K; Clancy-Oliveri M; Brown SA; Anderson SM; DeBoer MD; Cherñavvsky DR; Breton MD
    Diabetes Technol Ther; 2020 Aug; 22(8):594-601. PubMed ID: 32119790
    [No Abstract]   [Full Text] [Related]  

  • 10. Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes.
    DeBoer MD; Breton MD; Wakeman C; Schertz EM; Emory EG; Robic JL; Kollar LL; Kovatchev BP; Cherñavvsky DR
    Diabetes Technol Ther; 2017 May; 19(5):293-298. PubMed ID: 28426239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellent Glycemic Control Maintained by Open-Source Hybrid Closed-Loop AndroidAPS During and After Sustained Physical Activity.
    Petruzelkova L; Soupal J; Plasova V; Jiranova P; Neuman V; Plachy L; Pruhova S; Sumnik Z; Obermannova B
    Diabetes Technol Ther; 2018 Nov; 20(11):744-750. PubMed ID: 30285476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multinational Home Use of Closed-Loop Control Is Safe and Effective.
    Anderson SM; Raghinaru D; Pinsker JE; Boscari F; Renard E; Buckingham BA; Nimri R; Doyle FJ; Brown SA; Keith-Hynes P; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Farret A; Place J; Ly TT; Shanmugham S; Phillip M; Dassau E; Dasanayake IS; Kollman C; Lum JW; Beck RW; Kovatchev B;
    Diabetes Care; 2016 Jul; 39(7):1143-50. PubMed ID: 27208316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp.
    Ly TT; Breton MD; Keith-Hynes P; De Salvo D; Clinton P; Benassi K; Mize B; Chernavvsky D; Place J; Wilson DM; Kovatchev BP; Buckingham BA
    Diabetes Care; 2014 Aug; 37(8):2310-6. PubMed ID: 24879841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
    Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Look at Control-IQ: A New-Generation Automated Insulin Delivery System.
    Brown S; Raghinaru D; Emory E; Kovatchev B
    Diabetes Care; 2018 Dec; 41(12):2634-2636. PubMed ID: 30305346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home Use of an Artificial Beta Cell in Type 1 Diabetes.
    Thabit H; Tauschmann M; Allen JM; Leelarathna L; Hartnell S; Wilinska ME; Acerini CL; Dellweg S; Benesch C; Heinemann L; Mader JK; Holzer M; Kojzar H; Exall J; Yong J; Pichierri J; Barnard KD; Kollman C; Cheng P; Hindmarsh PC; Campbell FM; Arnolds S; Pieber TR; Evans ML; Dunger DB; Hovorka R
    N Engl J Med; 2015 Nov; 373(22):2129-2140. PubMed ID: 26379095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Boughton CK; Hovorka R
    Diabet Med; 2019 Mar; 36(3):279-286. PubMed ID: 30183096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of SmartGuard Technology in the Prevention of Nocturnal Hypoglycemia After Prolonged Physical Activity.
    Petruzelkova L; Pickova K; Sumnik Z; Soupal J; Obermannova B
    Diabetes Technol Ther; 2017 May; 19(5):299-304. PubMed ID: 28520532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.
    Jacobs PG; El Youssef J; Reddy R; Resalat N; Branigan D; Condon J; Preiser N; Ramsey K; Jones M; Edwards C; Kuehl K; Leitschuh J; Rajhbeharrysingh U; Castle JR
    Diabetes Obes Metab; 2016 Nov; 18(11):1110-1119. PubMed ID: 27333970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas.
    Kovatchev BP; Renard E; Cobelli C; Zisser HC; Keith-Hynes P; Anderson SM; Brown SA; Chernavvsky DR; Breton MD; Mize LB; Farret A; Place J; Bruttomesso D; Del Favero S; Boscari F; Galasso S; Avogaro A; Magni L; Di Palma F; Toffanin C; Messori M; Dassau E; Doyle FJ
    Diabetes Care; 2014 Jul; 37(7):1789-96. PubMed ID: 24929429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.